RT @drteplinsky
@MPishvaian @NaokiNiikura @prat_aleix @NEJM Best #ASCO22 moment!!
RT @DrChowdharyMD@twitter.com
☢️ ⚡️ Excited to share our critical review highlighting key studies involving radiotherapy from #ASCO22!
Link: https://www.advancesradonc.org/article/S2452-1094(22)00213-5/fulltext
#radonc @OncoAlert@twitter.com @NorthsideGaMD@twitter.com
🐦🔗: https://twitter.com/DrChowdharyMD/status/1606086193921368068
RT @touchONCOLOGY
Can we achieve a 70% survival rate for all cancer patients in Europe by 2035? Here's @DrEricWiner's perspective based on the latest from the #EuropeanCancerSummit
#ASCO22 #CancerAction #cancer @SmilowCancer @YaleCancer @EuropeanCancer @ASCOPres @ASCO
#europeancancersummit #asco22 #canceraction #cancer
#medicine #oncology #radiationoncology #therapy #equity #genderequality #genderequity #asco #asco22 #asco2022 #radonc #healthequity #cancer
#medicine #oncology #RadiationOncology #therapy #equity #genderequality #GenderEquity #asco #asco22 #asco2022 #radonc #HealthEquity #cancer